Cost-effectiveness of testing and treatment for latent tuberculosis infection in residents born outside the United States with and without medical comorbidities in a …
A Tasillo, JA Salomon, TA Trikalinos… - JAMA internal …, 2017 - jamanetwork.com
Importance Testing for and treating latent tuberculosis infection (LTBI) is among the main
strategies to achieve TB elimination in the United States. The best approach to testing …
strategies to achieve TB elimination in the United States. The best approach to testing …
T-Spot.TB Outperforms Tuberculin Skin Test in Predicting Tuberculosis Disease
CC Leung, WC Yam, WW Yew, PL Ho… - American journal of …, 2010 - atsjournals.org
Rationale: Silicosis is a well-recognized risk factor for tuberculosis (TB). Objectives: To
compare T-Spot. TB with tuberculin skin test (TST) in predicting the development of TB …
compare T-Spot. TB with tuberculin skin test (TST) in predicting the development of TB …
Prospective comparison of QFT-GIT and T-SPOT. TB assays for diagnosis of active tuberculosis
F Du, L Xie, Y Zhang, F Gao, H Zhang, W Chen… - Scientific reports, 2018 - nature.com
Abstract T-SPOT. TB and QuantiFERON-TB Gold In-Tube (QFT-GIT) tests, as two
commercial blood assays for diagnosing active tuberculosis (ATB), are not yet fully …
commercial blood assays for diagnosing active tuberculosis (ATB), are not yet fully …
T cell-based diagnosis of childhood tuberculosis infection
A Lalvani, KA Millington - Current opinion in infectious diseases, 2007 - journals.lww.com
Although longitudinal studies quantifying risk of progression to tuberculosis in tuberculosis-
exposed children with positive TIGRA results are required urgently, the small but rapidly …
exposed children with positive TIGRA results are required urgently, the small but rapidly …
The microbiological diagnosis of tuberculous meningitis: results of H aydarpasa‐1 study
We aimed to provide data on the diagnosis of tuberculous meningitis (TBM) in this largest
case series ever reported. The Haydarpasa‐1 study involved patients with microbiologically …
case series ever reported. The Haydarpasa‐1 study involved patients with microbiologically …
Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment
Abstract Background: Interferon-γ (IFN-γ) assays are new tests for tuberculosis (TB)
infection, and T-cell responses may be correlated with antigen burden. However, it is …
infection, and T-cell responses may be correlated with antigen burden. However, it is …
Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic …
AM Dyrhol-Riise, G Gran, T Wentzel-Larsen… - BMC infectious …, 2010 - Springer
Background Interferon-gamma (IFN-γ) Release Assays (IGRA) are more specific than the
tuberculosis skin test (TST) in the diagnosis of latent tuberculosis (TB) infection (LTBI). We …
tuberculosis skin test (TST) in the diagnosis of latent tuberculosis (TB) infection (LTBI). We …
minimizing tuberculosis during anti‐tumour necrosis factor‐alpha treatment of inflammatory bowel disease
VS Theis, JM Rhodes - Alimentary pharmacology & …, 2008 - Wiley Online Library
Background Tumour necrosis factor (TNF)‐alpha inhibitors are a major advance in the
management of inflammatory bowel disease but increase the risk for tuberculosis (TB). Aim …
management of inflammatory bowel disease but increase the risk for tuberculosis (TB). Aim …
BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay
M Eisenhut, S Paranjothy, I Abubakar, S Bracebridge… - Vaccine, 2009 - Elsevier
AIMS: To investigate whether BCG vaccination, in addition to a reduction of active
tuberculosis, leads to a reduction of Mycobacterium tuberculosis infection during an …
tuberculosis, leads to a reduction of Mycobacterium tuberculosis infection during an …
Performance of two commercial blood IFN-γ release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-α treatment
M Bocchino, A Matarese, B Bellofiore… - European journal of …, 2008 - Springer
The reactivation of latent tuberculosis (TB) is a major complication of tumor necrosis factor
(TNF)-α inhibitors. Screening for TB infection is recommended before anti-TNF therapy is …
(TNF)-α inhibitors. Screening for TB infection is recommended before anti-TNF therapy is …